Widely regarded as the next frontier of medical advances, the promise of individualized treatment becomes a reality as a result of advances in understanding the cellular basis of diseases such as breast cancer. Scientists are now able to develop genetic therapies, as well as experiments to predict the patient's response to existing therapies.
Today, some women with newborn breast cancer and their doctors can make informed medical decisions about the Breast Cancer Assay. This service provides a wealth of genetic information from a woman's genitals to produce a Double Scale between zero and 100, indicating that she is at high, medium or low risk for her cancer to return after treatment.
It is intended for patients with node-negative breast cancer, an estrogen receptor-positive that can be treated with hormone therapy. About half of the 230,000 patients diagnosed with breast cancer in the United States each year enter this phase, and they are usually given chemotherapy, the most commonly used treatment with the most serious side effects. Medical research shows that chemotherapy has improved patient survival rates in only 4 out of 100 patients, yet thousands of women continue to choose this expensive and toxic treatment with only limited information about the response.
Recent research has shown that women with high recurrence rates are more likely to benefit from chemotherapy, while women with lower scores are less likely to benefit. In addition, only 25% of women fall into the high-risk group, compared to 50% in the low-risk group, indicating that this standard treatment is not appropriate for all patients.
Elizabeth Sloan of New York City is one of the many patients with breast cancer who may not be able to respond to chemotherapy. A diligent mother of two, Elizabeth was considering having another child when she was found to be only 40 years old. He wanted to avoid chemotherapy, with its side effects, short-term and long-term side effects, but he also wanted to be absolutely sure that it would not help him.
Working with her doctor, M.
No two women with breast cancer are exactly the same as providing information beyond the usual measures, such as age, tumor size and stage of tumor, in determining the chances of the disease recurring said peace of mind in choice for him.
For Susan of Denver, Colorado provided a different kind of peace of mind. Susan's Recurrence Score has shown that she has a high risk of recurrence of cancer, and will likely benefit greatly from chemotherapy - much to the surprise of her and her doctor.
Based on some of my tests, my doctor said that he would not recommend chemotherapy in any other way. I was shocked when I got my result, but I was very happy because I believe this test saved my life explained.
Elizabeth Sloan is also very grateful for the information she has received about the various cancers, so why treat everyone the same way with something so toxic? "It is remarkable that, in the end, doctors can distinguish one person from another - thank you very much."
A simple test that can only be prescribed by a doctor. It is performed on breast tissue removed during surgery for a normal lumpectomy, mastectomy or biopsy, meaning no further procedure is required.
You must be logged in to post a comment.